N. Frickhofen

Phase III Study of Weekly High-Dose Infusional Fluorouracil Plus Folinic Acid With or Without Irinotecan in Patients With Metastatic Colorectal Cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986

Claus Henning Köhne, Eric Van Cutsem, J. Wils et al. · Journal of Clinical Oncology · 2005 · 329 citations

Medicine, Oncology, Pharmacotherapy +16

Capecitabine can induce acute coronary syndrome similar to5-fluorouracil

N. Frickhofen, F.-J. Beck, Bo‐Hyun Jung et al. · Annals of Oncology · 2002 · 158 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

Stefan Kubicka, Richard Greil, Thierry André et al. · Annals of Oncology · 2013 · 103 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Randomized phase II trial of two dosing schedules of BI 2536, a novel Plk-1 inhibitor, in patients with relapsed advanced or metastatic non-small-cell lung cancer (NSCLC)

Joachim von Pawel, Martin Reck, W. Digel et al. · Journal of Clinical Oncology · 2008 · 21 citations

Medicine, Oncology, Pharmacology +15

A phase I dose escalation study of sunitinib in combination with gemcitabine + cisplatin for advanced non-small cell lung cancer (NSCLC)

Martin Reck, N. Frickhofen, U. Gatzemeier et al. · Journal of Clinical Oncology · 2007 · 20 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +12